1 / 8

U.S. Asthma Therapies Markets Growing Penetration of Combination Drugs Spur Growth

U.S. Asthma Therapies Markets Growing Penetration of Combination Drugs Spur Growth.

kasa
Download Presentation

U.S. Asthma Therapies Markets Growing Penetration of Combination Drugs Spur Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Asthma Therapies MarketsGrowing Penetration of Combination Drugs Spur Growth “The tremendous success of bronchodilator/-corticosteroid combination drugs will continue to drive growth in the asthma market, leaving single-agent therapies with limited growth opportunities to exploit throughout the forecast period” Pharmaceutical Biotech Analyst Team Frost & Sullivan

  2. Industry Trends • Growing Patient Penetration of Combination Drugs • Growing Acceptance of Dry Powder Inhaler Delivery Systems • Development of Innovative Pulmonary Delivery Systems

  3. Key Features • Frost & Sullivan provides: • Detailed insights into recent developments and trends • Drivers, restraints, challenges, and strategic recommendations • Analyst insights on ‘hot topics’ and emerging applications • in the U.S. Asthma Therapies Markets • Market sizing and competitive analysis • Market forecasts and market share analysis • Pricing analysis • Product, vendor and end user analysis

  4. What We Offer • Coverage: The United States • Proven methodology encompassing extensive primary and secondary data and research • Focused information and strategies that cover business and technology issues • Credible data and analysis highlighting industry dynamics • Winning strategies to help you create precise business plans

  5. Who Will Benefit? Current Market Participants • Find out how you compare to the competition • Assess current and future drivers and restraints • Determine and exploit new market share opportunities New Entrants • Analyze challenges associated with the industry • Calculate time scales for strategy implementation • Position yourself to capitalize on the market’s unmet needs Investment Community • Analyze long-term strategies of companies in the asthma therapies markets • Determine which participants will outperform the competition • Assess attractiveness of investing in the asthma therapies markets

  6. What’s Included Bronchodilators, subdivided into: • Short-Acting Beta2 Agonists • Long-Acting Beta2 Agonists • Anticholinergics • Methylxanthines Anti-Inflammatories, subdivided into: • Inhaled Corticosteroids • Anti-Leukotrienes • Mediator-Release Inhibitors • Other Emerging Anti-Inflammatory Therapeutics Bronchodilator/Corticosteroid Combinations Other Emerging Asthma Therapies

  7. Key Market Participants Ivax Pharmaceuticals, Inc. King Pharmaceuticals, Inc. Merck & Co., Inc. Morton Grove Pharmaceuticals Novartis Pharmaceuticals Purdue Pharmaceuticals Roxane Laboratories Savage Laboratories Schering-Plough Sepracor, Inc. Sheffield Pharmaceuticals Teva Pharmaceuticals UCB Pharma Wallace Pharmaceuticals Warrick Pharmaceuticals 3M Pharmaceuticals aaiPharma Abbott Laboratories Alpharma Apotex Corp. AstraZeneca Pharmaceuticals Aventis Pharmaceuticals, Inc. Boehringer Ingelheim Dey, Inc. Forest Laboratories, Inc. GlaxoSmithKline Impax Labs Inspire Pharmaceuticals Inwood Pharmaceuticals

  8. For More Information • Call toll free 877 GO FROST (877.463.7876) • Fax toll free 888.690.3329 • Email myfrost@frost.com • Visit www.frost.com

More Related